OCEA · Ocean Biomedical, Inc. · Executive Compensation
$0.01
-0.01 (-52.20%)
At close · Apr 24
Return incl. dividend (before tax)
Going-concern doubt
— flagged May 15, 2025
Substantial doubt about the company's ability to continue as a going concern.
“These events and conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these financial statements are issued.”View the 10-Q filed May 15, 2025
Market Cap
$348,547
Shares
232.37M
Volume · Apr 24
64.85M
Avg daily vol (3M)
63.22M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Elizabeth Ng | Chief Executive Officer | $6,811,560 |
| Daniel Behr | Executive Vice President and Head of External Innovation and Academic Partnerships | $3,405,780 |
| Jonathan Heller | Former Chief Science Officer and Head of Research and Development | $1,702,890 |
| Gurinder Kalra | Chief Financial Officer | $1,135,260 |
| Inderjote Kathuria | Chief Strategy Officer | $1,135,260 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Gurinder Kalra | Chief Financial Officer | — |
| Jonathan Heller | Former Chief Science Officer and Head of Research and Development | — |
| Inderjote Kathuria | Chief Strategy Officer | — |
| Daniel Behr | Executive Vice President and Head of External Innovation and Academic Partnerships | — |
| Elizabeth Ng | Chief Executive Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jolie Kahn | CFO | Resigned | 2025-08-05 |
| Michael Petersen | director | Resigned | 2025-08-05 |
| Jake Kurtis | director | Resigned | 2025-04-23 |
| M. Michelle Berrey | Interim Chief Executive Officer | Appointed | 2024-10-29 |
| Amy Griffith | director | Appointed | 2024-03-08 |
| Gurinder Kalra | Chief Financial Officer | Resigned | 2024-03-04 |
| Jolie Kahn | Chief Financial Officer | Appointed | 2024-03-04 |
| Jerome Ringo | member of Ocean Biomedical's board of directors | Resigned | 2023-10-12 |
| Jerome Ringo | Class I Director | Appointed | 2023-02-15 |
| Michael Peterson | Class II Director | Appointed | 2023-02-15 |
| Jack A. Elias | Class II Director | Appointed | 2023-02-15 |
| Jonathan Kurtis | Class I Director | Appointed | 2023-02-15 |
| William Owens | Class I Director | Appointed | 2023-02-15 |
| Michelle Berrey | Class I Director | Appointed | 2023-02-15 |
| Suren Ajjarapu | Class III Director | Appointed | 2023-02-15 |
| Chirinjeev Kathuria | Founder, Executive Chairman, Class III Director | Appointed | 2023-02-15 |
| Martin D. Angle | Class II Director | Appointed | 2023-02-15 |
| Inderjote Kathuria | Chief Strategy Officer | Appointed | 2023-02-15 |
| Daniel Behr | Executive Vice President and Head of External Innovation and Academic Partnerships | Appointed | 2023-02-15 |
| Robert Sweeney | Chief Accounting Officer | Appointed | 2023-02-15 |
| Gurinder Kalra | Chief Financial Officer | Appointed | 2023-02-15 |
| Elizabeth Ng | Chief Executive Officer and Class III Director | Appointed | 2023-02-15 |
| Jerome Ringo | Class I Director | Appointed | 2023-02-15 |
| Michael Peterson | Class II Director | Appointed | 2023-02-15 |
| William Owens | Class I Director | Appointed | 2023-02-15 |
Leadership
- M. Michelle Berrey CEO
- Michelle Berrey CEO, Board Member
- Chirinjeev Kathuria Chairman
- Dr. Chirinjeev Kathuria Chairman
- Gurinder Kalra CFO
- Jolie Kahn CFO
- Robert Sweeney Chief Accounting Officer
- Amy Griffith Board Member
- Dr. Jack Elias Board Member
- Elizabeth Ng Board Member
- Jack A. Elias Board Member
- Jerome Ringo Board Member
- Jonathan Kurtis Board Member
- Michael L. Peterson Board Member
- Michael Peterson Board Member
- Suren Ajjarapu Board Member
- William Owens Board Member